These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1067 related items for PubMed ID: 19215563
21. Monitoring alendronate therapy for osteoporosis. Braga de Castro Machado A, Hannon R, Eastell R. J Bone Miner Res; 1999 Apr; 14(4):602-8. PubMed ID: 10234582 [Abstract] [Full Text] [Related]
22. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD. J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013 [Abstract] [Full Text] [Related]
23. Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss. Choi HJ, Im JA, Kim SH. Maturitas; 2008 Jun 20; 60(2):170-6. PubMed ID: 18572334 [Abstract] [Full Text] [Related]
24. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates. Confavreux CB, Fontana A, Guastalla JP, Munoz F, Brun J, Delmas PD. Bone; 2007 Sep 20; 41(3):346-52. PubMed ID: 17618847 [Abstract] [Full Text] [Related]
25. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects. Mangiafico RA, Malaponte G, Pennisi P, Li Volti G, Trovato G, Mangiafico M, Bevelacqua Y, Mazza F, Fiore CE. J Intern Med; 2007 Jun 20; 261(6):587-96. PubMed ID: 17547714 [Abstract] [Full Text] [Related]
26. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women. Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T. Menopause; 2008 Jun 20; 15(2):369-73. PubMed ID: 17882010 [Abstract] [Full Text] [Related]
27. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats. Brzóska MM, Moniuszko-Jakoniuk J. Bone; 2004 Nov 20; 35(5):1180-91. PubMed ID: 15542044 [Abstract] [Full Text] [Related]
28. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis. Piatek S, Adolf D, Wex T, Halangk W, Klose S, Westphal S, Amthauer H, Winckler S. Maturitas; 2013 Apr 20; 74(4):363-8. PubMed ID: 23391500 [Abstract] [Full Text] [Related]
29. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Akin O, Göl K, Aktürk M, Erkaya S. Gynecol Endocrinol; 2003 Feb 20; 17(1):19-29. PubMed ID: 12724015 [Abstract] [Full Text] [Related]
30. [Biochemical markers of age-related changes in bones turnover and bone mineral density in healthy Chinese men]. Jiang YX, Tang SY, Wu XP, Yang LF, Liao EY. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan 20; 33(1):53-6. PubMed ID: 18245905 [Abstract] [Full Text] [Related]
31. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y. Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265 [Abstract] [Full Text] [Related]
32. C-telopeptides of type I collagen in postmenopausal women: an experience in a Tunisian clinical laboratory. Bouzid K, Bahlous A, Kalaï E, Fellah H, Sahli H, Sellami S, Abdelmoula J. Tunis Med; 2010 Jul 22; 88(7):467-9. PubMed ID: 20582880 [Abstract] [Full Text] [Related]
33. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. Dane C, Dane B, Cetin A, Erginbas M. Gynecol Endocrinol; 2007 Jul 22; 23(7):398-403. PubMed ID: 17701771 [Abstract] [Full Text] [Related]
34. Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy. Fink E, Cormier C, Steinmetz P, Kindermans C, Le Bouc Y, Souberbielle JC. Osteoporos Int; 2000 Jul 22; 11(4):295-303. PubMed ID: 10928218 [Abstract] [Full Text] [Related]
35. [Effect of physical activity on bone turnover in young boys]. Kalaï E, Bahlous A, Nbigh A, Sahli H, Sellami S, Abdelmoula J. Ann Biol Clin (Paris); 2007 Jul 22; 65(5):519-24. PubMed ID: 17913670 [Abstract] [Full Text] [Related]
36. Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis. Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G. Ann N Y Acad Sci; 2009 Sep 22; 1173 Suppl 1():E60-3. PubMed ID: 19751416 [Abstract] [Full Text] [Related]
37. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Löfman O, Magnusson P, Toss G, Larsson L. Clin Chim Acta; 2005 Jun 22; 356(1-2):67-75. PubMed ID: 15936304 [Abstract] [Full Text] [Related]
38. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study. Łukaszkiewicz J, Karczmarewicz E, Płudowski P, Jaworski M, Czerwiński E, Lewiński A, Marcinowska-Suchowierska E, Milewicz A, Spaczyński M, Lorenc RS, EPOLOS Group. Med Sci Monit; 2008 Dec 22; 14(12):PH65-70. PubMed ID: 19043376 [Abstract] [Full Text] [Related]
39. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH. Clin Chim Acta; 2010 May 02; 411(9-10):771-5. PubMed ID: 20184866 [Abstract] [Full Text] [Related]
40. Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region, Poland. Filip RS, Zagórski J. Ann Agric Environ Med; 2004 May 02; 11(2):255-9. PubMed ID: 15627333 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]